Author/s—Year | Study Design | Population | Intervention | Analyzed Results | Main Conclusions | |||
---|---|---|---|---|---|---|---|---|
Zamora et al., 1995 [29] | Placebo-controlled, double-blind, randomized | 24 ♂ healthy students; 22.9 ± 2.1 y; 68.0 ± 8.7 Kg; 178.1 ± 6.6 cm; Body fat 11.2 ± 4.4 % PbG n = 12 ♂ 22.5 ± 2.0 y; 67.3 ± 7.0 Kg; 177.4 ± 7.0 cm; Body fat 10.1 ± 3.9 % SeG n = 12 ♂ 23.28 ± 2.36 y; 68.78 ± 10.44 Kg; 178.7 ± 6.3 cm; Body fat 12.3 ± 4.8 % |
Supplementation: 180 μg Se (Seleniomethionine) once per day * 10-week period PhA: 10-week endurance training programme (3 sessions per week) after a 4-week period of restricted |
At rest | Post-PhA | |||
Pre-PhA vs. Post-PhA | SeG vs. PbG | Pre-PhA vs. Post-PhA | SeG vs. PbG | |||||
Muscle mitochondria morphometric parameters QA Aa â |
↑*SelG ↔ PbG ↑*SelGr ↔ PbG ↔ SelGr ↔ PbG |
#SelGr vs PbG #SelGr vs PbG #SelGr vs PbG |
↑*SelG ↔ PbG ↑*SelG ↔ PbG ↔ SelGr ↔ PbG |
#SelGr vs PbG ↔ SelGr vs PbG #SelGr vs PbG |
||||
VO2max | ↔ SelGr ↔ PbG | † SelGr vs PbG | ↔ SelGr ↔ PbG | † SelGr vs PbG | ||||
Body fat % | ↔ SelGr ↔ PbG | † SelGr vs PbG | ↔ SelGr ↔ PbG | † SelGr vs PbG | ||||
BMI Kg*m2 | ↔ SelGr ↔ PbG | † SelGr vs PbG | ↔ SelGr ↔ PbG | † SelGr vs PbG | ||||
Tessier et al., 1995 [30] | Placebo-controlled, double-blind, randomized | 24 ♂ healthy; 22.9 ± 2.1 y |
Supplementation: 240 μg organic selenium (70% selenomethionine) Selenion® once per day *10-week period PhA: 4-week deconditioning period with no training, followed by running endurance training lasting 10 week (3 sessions/week). |
Pre-PhA vs. Post-PhA | SeG vs. PbG | |||
[Se] | ↑*SelG ↓PbG | † SelGr vs PbG | ||||||
Vitamin E | ↓SelG ↑PbG | † SelGr vs PbG | ||||||
GPx muscle | ||||||||
PhA cronic | ↓SelG ↓PbG | † SelGr vs PbG | ||||||
PhA acute | ↑*SelG ↓*PbG | # SelGr vs PbG |
♂: Men; ♀: Women; NW: Normal weight; OW: Over weight; y: Years; Kg: Kilograms; m: Meters; cm: Centimeters; BMI: Body mass index; PhA: Physical activity; Se: Selenium; [Se]: Plasma Selenium levels; ↑*: Statistically significant increase; ↑: Non-statistical increase; ↓*: Statistically significant decrease; ↓: Non-statistical decrease; †: Change without statistical significance; #: Change statistical significance; ↔: Without changes; LH: Lipid hydroperoxidase; GSH: Reduced glutathione; SOD: Superoxide dismutase; TAS: Total antioxidant status; PbG: Placebo group; SeG: Selenium group; GTtotal: Glutathione total; GSSG: Glutathione oxidized; GPx: Glutathione peroxidase; EGPx: Erythrocyte glutathione peroxidase; EGR: Erythrocyte glutathione reductase; VO2max: Maximum oxygen consumption; Tt: Total testosterone; Tf: Testosterone free; [La]: Plasma lactate; CK: Creatine kinase; Cyt Ox: Cytochrome C oxidase; SDH: Succinate dehydrogenase; MCH: Myosin heavy chains; QA: Density of the mitochondria profile; Aa: surface of all the mitochondria profile area; â: mean surface of individual mitochondria profile area.